Macau Casino Gambli...
Health Care: Drugs
Alnylam Pharmaceuticals Inc. (ALNY: NASDAQ)
$10.09 -0.15 | -1.46%
06/01/12 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 153,583 | 155,679 | 37,098 | 6,433 | 4,337 | 2,222 | 0 |
| Shares Bought | 153,583 | 155,679 | 37,098 | 6,433 | 4,337 | 2,222 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 35.08M | 26.63M | 32.45M | 31.94M | 31.79M | 31.79M | 31.78M |
| Shares Bought | 12.05M | 3.44M | 8.39M | 7.96M | 8.84M | 8.84M | 8.83M |
| Shares Sold | 1.64M | 2.14M | 2.50M | 2.57M | 1.66M | 1.66M | 1.66M |
Portfolios with ALNY
- Portfolio NameUser Type
- UserThe #1 Growth Fund To Make ...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- Userkite
- UserPART 6 JPMorgan 28th Annual...
- UserWilliam T Blanchard - Medical
- ContributorHealthcare Short Squeezes f...
- UserS.A.Chili
- UserHancock Hallock Firm
Latest ALNY Headlines from TheStreet
- 5 Stocks Insiders Love Right Now 02.24.12 | 12:02 pm
- 8 Stocks Rising on Huge Volume 02.15.12 | 02:02 pm
- 'Mad Money Lightning Round': Stay Long Sandridge 01.03.12 | 07:01 pm
- Cramer's 'Mad Money' Recap: Betting Against the Bears (Update 2) 01.03.12 | 06:01 pm
- AK Steel, Applied Materials: New Ratings 02.23.11 | 09:02 am
- Layoffs Mount in 2010: What Does It Mean for 2011? 01.06.11 | 05:01 pm
- Alnylam Pharmaceuticals CEO Discusses Q3 2010 Results  Earnings Call Transcript 11.03.10 | 10:11 pm
- Biotech Stock Mailbag: Cyclacel Pharma 10.08.10 | 07:10 am
- Alnylam Cuts Jobs On Partner Exit 09.24.10 | 07:09 am
- Alnylam Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript 08.05.10 | 12:08 am
Press Releases for ALNY
- Alnylam Announces Top-Line Results Of Phase IIb Clinical Trial Of ALN-RSV01, An Inhaled RNAi Therapeutic For The Treatment Of Respiratory Syncytial Virus (RSV) Infection - Business Wire 05.30.12 | 06:05 am
- Alnylam And PBL Sign License Agreement For Baulcombe & Hamilton RNAi Patent - Business Wire 05.23.12 | 08:05 am
- Alnylam Pharmaceuticals Reports First Quarter 2012 Financial Results - Business Wire 05.03.12 | 04:05 pm
- Alnylam To Webcast Conference Call Discussing First Quarter 2012 Financial Results - Business Wire 04.26.12 | 04:04 pm
- Alnylam To Webcast Presentation At Future Leaders In The Biotech Industry Conference - Business Wire 04.13.12 | 04:04 pm
- Alnylam To Webcast Presentation At 11th Annual Needham Healthcare Conference - Business Wire 03.27.12 | 04:03 pm
- Alnylam Initiates Phase I Clinical Study Of ALN-TTR02, An RNAi Therapeutic Targeting Transthyretin (TTR) For The Treatment Of TTR-Mediated Amyloidosis (ATTR) - Business Wire 03.19.12 | 08:03 am
- Alnylam Retains Key Claims For Kinesin Spindle Protein (KSP) RNAi Patent In Interference Proceedings - Business Wire 03.14.12 | 06:03 am
- Alnylam To Webcast Presentation At Barclays Capital Global Healthcare Conference - Business Wire 03.06.12 | 04:03 pm
- Alnylam And The University Of Massachusetts Medical School Announce Tuschl I Patent Upheld In European Opposition Proceedings - Business Wire 03.01.12 | 11:03 am
Partner Headlines for ALNY
- The Zacks Analyst Blog Highlights: Amgen, Sanofi, Regeneron, Alnylam and Coach - Press Releases - Zacks 03.28.12 | 09:03 am
- What Alnylam Doesn't Want You To Know - Seeking Alpha 03.16.12 | 09:03 am
- Tekmira: RNAi Company With Long Term Potential, Short Term Catalysts - Seeking Alpha 03.07.12 | 08:03 am
- Company News for February 15, 2012 - Corporate Summary - Zacks 02.15.12 | 10:02 am
- Alnylam Pharma Up 8% After Pricing Public Offering - Benzinga 02.15.12 | 09:02 am
- Alnylam Delivers In-Line Numbers - Analyst Blog - Zacks 02.13.12 | 10:02 am
- Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach - Seeking Alpha 01.30.12 | 09:01 am
- Alnylam Down to Neutral - Analyst Blog - Zacks 01.20.12 | 04:01 pm
- 16 Healthcare Stocks Deeply Discounted From Target Price - Seeking Alpha 01.12.12 | 09:01 am
- Alnylam States Preclinical Data - Analyst Blog - Zacks 12.30.11 | 04:12 pm
